Human Longevity, Inc.
Author: Michael
Rubedo Life Sciences reported preliminary Phase 1
Fresh funding backs a high-stakes attempt to do
SEMCAP is betting that longevity’s next growth
Immortal Dragons-backed Unlimited Bio registers
New data link popular weight-loss drugs to highe
Deal worth up to $150m comes as supplementation
20/20 BioLabs has entered an exclusive U.S.
20/20 BioLabs has entered an exclusive U.S.
Anavex Life Sciences withdrew its marketing autho